PharmaResearch Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 6, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	3,532,480	2,727,283	1,116,952	697,316	818,025	552,155
Market Cap Growth	35.46%	144.17%	60.18%	-14.76%	48.15%	60.62%
Enterprise Value	3,233,065	2,575,782	990,868	612,568	761,136	536,011
Last Close Price	340000.00	259933.95	107975.22	68322.03	79394.26	54984.38
PE Ratio	23.41	29.63	14.59	17.18	17.52	16.85
Forward PE	17.56	22.06	12.55	10.92	14.49	15.04
PS Ratio	7.12	7.79	4.28	3.58	5.31	5.08
PB Ratio	5.12	4.78	2.42	1.88	2.49	2.09
P/TBV Ratio	5.62	5.38	2.77	2.27	3.10	2.67
P/FCF Ratio	28.08	26.82	21.12	16.55	18.32	-
P/OCF Ratio	21.93	19.75	17.20	11.74	12.53	17.05
EV/Sales Ratio	6.52	7.36	3.80	3.15	4.94	4.93
EV/EBITDA Ratio	15.26	18.44	9.50	8.01	12.27	12.83
EV/EBIT Ratio	16.48	20.43	10.74	9.29	14.50	16.04
EV/FCF Ratio	25.70	25.33	18.74	14.53	17.05	-
Debt / Equity Ratio	0.31	0.37	0.07	0.18	0.20	0.12
Debt / EBITDA Ratio	1.00	1.49	0.33	0.87	1.06	0.78
Debt / FCF Ratio	1.68	2.05	0.65	1.58	1.47	-
Asset Turnover	0.61	0.50	0.52	0.43	0.41	0.37
Inventory Turnover	1.91	1.84	1.90	2.55	2.40	2.07
Quick Ratio	6.55	5.84	2.96	4.04	3.86	2.87
Current Ratio	7.57	6.75	3.89	4.56	4.31	3.55
Return on Equity (ROE)	23.58%	17.23%	18.53%	12.41%	15.80%	13.17%
Return on Assets (ROA)	15.05%	11.33%	11.38%	9.10%	8.78%	7.08%
Return on Invested Capital (ROIC)	41.17%	28.57%	23.98%	21.57%	19.29%	13.79%
Return on Capital Employed (ROCE)	21.90%	16.30%	19.70%	15.60%	13.80%	11.80%
Earnings Yield	4.28%	3.38%	6.85%	5.82%	5.71%	5.94%
FCF Yield	3.56%	3.73%	4.74%	6.04%	5.46%	-0.43%
Dividend Yield	0.32%	0.42%	0.88%	0.97%	0.76%	0.91%
Payout Ratio	7.94%	10.96%	9.84%	15.56%	10.77%	9.04%
Buyback Yield / Dilution	-4.63%	2.50%	-5.85%	0.76%	-5.74%	-0.73%
Total Shareholder Return	-4.31%	2.93%	-4.96%	1.73%	-4.99%	0.18%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.